We are honored to announce that ICER’s President, Steve Pearson, MD, MSc is among those leaders selected for STAT’s 2023 STATUS List. Each year, STAT recognizes standout individuals in health, medicine, and science. According to STAT:
“ICER, the nonprofit founded by physician and bioethicist Pearson, has become perhaps the most prominent independent arbiter on the critical issue of fair drug pricing, with its findings increasingly impacting what payers are willing to shell out for drugs. ICER recently weighed in on lecanemab, the closely watched Alzheimer’s drug from Eisai and Biogen granted accelerated approval by the FDA in January and now sold as Leqembi.”
